Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRIVESHAFT: Once-daily vs Twice-daily Darunavir/Ritonavir in HIV
NCT01423812Phase 4Completed
- Sponsor
- Ruth M. Rothstein CORE Center
- Start
- Jan 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Ruth M. Rothstein CORE Center. Started Jan 2012; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01423812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01423812.